RAPTOR RESOURCES LIMITED - Announcements

0.00%

20.5¢

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

ResApp Health Limited is an Australia-based digital health company engaged in developing... ResApp Health Limited is an Australia-based digital health company engaged in developing smartphone applications for the diagnosis and management of respiratory disease. The Company provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The Company is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers. The Company’s machine learning algorithms use sound to diagnose and measure the severity of respiratory conditions without the need for additional accessories or hardware. Its products include ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department and primary care settings; and SleepCheck, a smartphone application which allows consumers to self-assess their risk of sleep apnoea. Its obstructive sleep aponia screening test uses overnight breathing and snoring sounds recorded on a smartphone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

RAP	Appendix 3B & Section 708A Notice		16/12/16	1.12MB	Share
RAP	ResApp Initiates SMARTCOUGH-C Study in the US	PRICE SENSITIVE	09/12/16	74.64KB	Share
RAP	ResApp to Present at Wilsons Healthcare IT Conference		28/11/16	77.16KB	Share
RAP	Patersons Securities Initiates Research Coverage		16/11/16	63.95KB	Share
RAP	ResApp Receives IRB Approval at Texas Children's Hospital	PRICE SENSITIVE	16/11/16	69.63KB	Share
RAP	Change of Director's Interest Notice x 4		11/11/16	756.25KB	Share
RAP	Appendix 3B		11/11/16	668.52KB	Share
RAP	ResApp Receives IRB Approval at Massachusetts General	PRICE SENSITIVE	11/11/16	69.98KB	Share
RAP	Confirmation of Change of Auditor		09/11/16	463.33KB	Share
RAP	Results of Annual General Meeting-RAP.AX		02/11/16	362.67KB	Share
RAP	2016 Letter to Shareholders-RAP.AX		02/11/16	83.95KB	Share
RAP	Appendix 4C - quarterly-RAP.AX	PRICE SENSITIVE	28/10/16	1015.93KB	Share
RAP	Appendix 3B & Section 708A Notice-RAP.AX		27/10/16	255.78KB	Share
RAP	RAP receives Australian Emerging Company of Year Award-RAP.AX		25/10/16	106.33KB	Share
RAP	ResApp Receives First Institutional Review Board Approval-RAP.AX	PRICE SENSITIVE	21/10/16	70.66KB	Share
RAP	ResApp Investor Presentation-RAP.AX		18/10/16	4.4MB	Share
RAP	ResApp Wins Innovation Excellence Award at Tech23 2016-RAP.AX		12/10/16	67.27KB	Share
RAP	Appendix 3B & Section 708A Notice-RAP.AX		07/10/16	811.41KB	Share
RAP	Notice of Annual General Meeting-RAP.AX		04/10/16	7.4MB	Share
RAP	Further Positive Results From Adult Clinical Study-RAP.AX	PRICE SENSITIVE	03/10/16	99.2KB	Share
RAP	Trading Halt-RAP.AX	PRICE SENSITIVE	29/09/16	413.73KB	Share
RAP	Appendix 4G-RAP.AX		28/09/16	218.49KB	Share
RAP	Annual Report 2016-RAP.AX		28/09/16	1.69MB	Share
RAP	Appendix 3B & Section 708A Notice-RAP.AX		16/09/16	1022.53KB	Share
RAP	ResApp Begins Evaluation with Humanitarian Organisation-RAP.AX	PRICE SENSITIVE	15/09/16	70.68KB	Share
RAP	Change in substantial holding-RAP.AX		09/09/16	212.23KB	Share
RAP	Appendix 4E - Preliminary Final Report-RAP.AX	PRICE SENSITIVE	31/08/16	388.64KB	Share
RAP	ResApp Wins Global Grand Finals at Talent Unleashed Awards-RAP.AX		19/08/16	68.76KB	Share
RAP	ResApp Expands into Management of Respiratory Disease-RAP.AX	PRICE SENSITIVE	18/08/16	83.81KB	Share
RAP	Change of Auditor-RAP.AX		04/08/16	34.61KB	Share
RAP	Appendix 4C - quarterly-RAP.AX	PRICE SENSITIVE	29/07/16	84.39KB	Share
RAP	Bioshares Biotech Summit Presentation-RAP.AX		29/07/16	5.08MB	Share
RAP	Section 708A Notice-RAP.AX		22/07/16	123.09KB	Share
RAP	Appendix 3B-RAP.AX		22/07/16	561.27KB	Share
RAP	ResApp Wins Category at the 2016 Talent Unleashed Awards-RAP.AX		22/07/16	69.15KB	Share
RAP	Massachusetts General Hospital for US Clinical Study Site-RAP.AX	PRICE SENSITIVE	20/07/16	72.84KB	Share
RAP	Becoming a substantial holder-RAP.AX		20/07/16	290.25KB	Share
RAP	Appendix 3B-RAP.AX		15/07/16	149.05KB	Share
RAP	Ceasing to be a substantial holder-RAP.AX		07/07/16	96.84KB	Share
RAP	Ceasing to be a substantial holder-RAP.AX		07/07/16	94.81KB	Share
RAP	Appendix 3B-RAP.AX		07/07/16	149.3KB	Share
RAP	Response to ASX Price and Volume Query-RAP.AX	PRICE SENSITIVE	07/07/16	272.02KB	Share
RAP	Update on US Clinical Study-RAP.AX	PRICE SENSITIVE	30/06/16	71.39KB	Share
RAP	Appendix 3B-RAP.AX		28/06/16	149.11KB	Share
RAP	Positive Preliminary Results from Adult Clinical Study-RAP.AX	PRICE SENSITIVE	21/06/16	112.38KB	Share
RAP	Trading Halt-RAP.AX	PRICE SENSITIVE	20/06/16	365.45KB	Share
RAP	Release of Restricted Securities-RAP.AX		10/06/16	86.94KB	Share
RAP	Appendix 3B-RAP.AX		10/06/16	149.41KB	Share
RAP	ResApp Provides Australian Adult Study Enrolment Update-RAP.AX	PRICE SENSITIVE	07/06/16	390.91KB	Share
RAP	Appendix 3B - Exercise of Options-RAP.AX		02/06/16	149.46KB	Share
RAP	Appendix 3B - Release of Restricted Securities-RAP.AX		02/06/16	148.8KB	Share
RAP	Release of Restricted Securities-RAP.AX		18/05/16	88.55KB	Share
RAP	Appendix 3B-RAP.AX		18/05/16	149.44KB	Share
RAP	Ceasing to be a substantial holder-RAP.AX		16/05/16	49.29KB	Share
RAP	Investor Presentation-RAP.AX		03/05/16	5.02MB	Share
RAP	Appendix 4C - quarterly-RAP.AX	PRICE SENSITIVE	29/04/16	84.32KB	Share
RAP	Appendix 3B and Issue of Cleansing Prospectus-RAP.AX		29/04/16	298.96KB	Share
RAP	Cleansing Prospectus-RAP.AX	PRICE SENSITIVE	28/04/16	402.65KB	Share
RAP	ResApp Completes Oversubscribed $12.5M Capital Raising-RAP.AX	PRICE SENSITIVE	20/04/16	80.21KB	Share
RAP	TechKnow Invest Roadshow 2016 Presentation-RAP.AX		05/04/16	4.98MB	Share
RAP	ResApp Provides Updated Paediatric Clinical Study Results	PRICE SENSITIVE	31/03/16	109.37KB	Share
RAP	Director Resignation and Appendix 3Z		23/03/16	119.03KB	Share
RAP	Change of Director's Interest Notice		18/03/16	77.54KB	Share
RAP	Response to ASX Aware Query	PRICE SENSITIVE	17/03/16	751.45KB	Share
RAP	ResApp Presentation at the ASX CEO Sessions		15/03/16	5.21MB	Share
RAP	ResApp Completes Successful Pre-Submission Meeting with FDA	PRICE SENSITIVE	14/03/16	75.4KB	Share
RAP	Terms of Executive Appointment		11/03/16	87.38KB	Share
RAP	Response to ASX Price and Volume Query	PRICE SENSITIVE	11/03/16	238.77KB	Share
RAP	ResApp Collaborates with Leading Humanitarian Organisation	PRICE SENSITIVE	07/03/16	70.88KB	Share
RAP	Breakthrough Performance in Paediatric Clinical Study	PRICE SENSITIVE	02/03/16	95.7KB	Share
RAP	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	01/03/16	1.23MB	Share
RAP	Second Site Added to Adult Clinical Study	PRICE SENSITIVE	26/02/16	69.69KB	Share
RAP	Initial Director's Interest Notice		24/02/16	22.79KB	Share
RAP	ResApp Appoints New Director		22/02/16	68.43KB	Share
RAP	Investor Presentation		17/02/16	5.21MB	Share
RAP	Appendix 3B		11/02/16	148.51KB	Share
RAP	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	84.13KB	Share
RAP	Change in substantial holding		27/01/16	211.46KB	Share
RAP	Appendix 3B		22/01/16	561.96KB	Share
RAP	Conversion of Options and Issue of Cleansing Prospectus		22/01/16	67.09KB	Share
RAP	Cleansing Prospectus	PRICE SENSITIVE	22/01/16	427.53KB	Share
RAP	ResApp to Exhibit at Digital Healthcare Conference in Dubai		22/01/16	70.1KB	Share
RAP	ResApp Files Pre-Submission Package with the US FDA		31/12/15	71.11KB	Share
RAP	Appendix 3B		21/12/15	148.45KB	Share
RAP	ResApp Receives Approval to Begin Adult Study	PRICE SENSITIVE	14/12/15	69.99KB	Share
RAP	Release of Restricted Securities		04/12/15	87.89KB	Share
RAP	Result of Annual General Meeting		30/11/15	134.33KB	Share
RAP	CEO Presentation at Canary Networks Investor Roadshow		25/11/15	1.85MB	Share
RAP	Becoming a substantial holder		16/11/15	71.43KB	Share
RAP	US Roadshow - Investor Presentation		11/11/15	2.62MB	Share
RAP	Further Positive Preliminary Results from Clinical Study	PRICE SENSITIVE	10/11/15	169.57KB	Share
RAP	Trading Halt	PRICE SENSITIVE	06/11/15	201.42KB	Share
RAP	Exhibitor at McKinsey Global Integrated Care Conference		04/11/15	103.38KB	Share
RAP	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	125.94KB	Share
RAP	Notice of Annual General Meeting/Proxy Form		28/10/15	138.34KB	Share
RAP	Dr Abeyratne to present at Pneumonia Innovations Summit		22/10/15	89.67KB	Share
RAP	TechKnow Invest Roadshow Presentation		20/10/15	2.84MB	Share
RAP	Change of Director's Interest Notice		12/10/15	36.05KB	Share
RAP	Australia Biotech Invest Presentation		06/10/15	2.3MB	Share
RAP	Appendix 4G		01/10/15	129.83KB	Share

RAP Appendix 3B & Section 708A Notice
16/12/16		1.12MB	Share
RAP ResApp Initiates SMARTCOUGH-C Study in the US
09/12/16	PRICE SENSITIVE	74.64KB	Share
RAP ResApp to Present at Wilsons Healthcare IT Conference
28/11/16		77.16KB	Share
RAP Patersons Securities Initiates Research Coverage
16/11/16		63.95KB	Share
RAP ResApp Receives IRB Approval at Texas Children's Hospital
16/11/16	PRICE SENSITIVE	69.63KB	Share
RAP Change of Director's Interest Notice x 4
11/11/16		756.25KB	Share
RAP Appendix 3B
11/11/16		668.52KB	Share
RAP ResApp Receives IRB Approval at Massachusetts General
11/11/16	PRICE SENSITIVE	69.98KB	Share
RAP Confirmation of Change of Auditor
09/11/16		463.33KB	Share
RAP Results of Annual General Meeting-RAP.AX
02/11/16		362.67KB	Share
RAP 2016 Letter to Shareholders-RAP.AX
02/11/16		83.95KB	Share
RAP Appendix 4C - quarterly-RAP.AX
28/10/16	PRICE SENSITIVE	1015.93KB	Share
RAP Appendix 3B & Section 708A Notice-RAP.AX
27/10/16		255.78KB	Share
RAP RAP receives Australian Emerging Company of Year Award-RAP.AX
25/10/16		106.33KB	Share
RAP ResApp Receives First Institutional Review Board Approval-RAP.AX
21/10/16	PRICE SENSITIVE	70.66KB	Share
RAP ResApp Investor Presentation-RAP.AX
18/10/16		4.4MB	Share
RAP ResApp Wins Innovation Excellence Award at Tech23 2016-RAP.AX
12/10/16		67.27KB	Share
RAP Appendix 3B & Section 708A Notice-RAP.AX
07/10/16		811.41KB	Share
RAP Notice of Annual General Meeting-RAP.AX
04/10/16		7.4MB	Share
RAP Further Positive Results From Adult Clinical Study-RAP.AX
03/10/16	PRICE SENSITIVE	99.2KB	Share
RAP Trading Halt-RAP.AX
29/09/16	PRICE SENSITIVE	413.73KB	Share
RAP Appendix 4G-RAP.AX
28/09/16		218.49KB	Share
RAP Annual Report 2016-RAP.AX
28/09/16		1.69MB	Share
RAP Appendix 3B & Section 708A Notice-RAP.AX
16/09/16		1022.53KB	Share
RAP ResApp Begins Evaluation with Humanitarian Organisation-RAP.AX
15/09/16	PRICE SENSITIVE	70.68KB	Share
RAP Change in substantial holding-RAP.AX
09/09/16		212.23KB	Share
RAP Appendix 4E - Preliminary Final Report-RAP.AX
31/08/16	PRICE SENSITIVE	388.64KB	Share
RAP ResApp Wins Global Grand Finals at Talent Unleashed Awards-RAP.AX
19/08/16		68.76KB	Share
RAP ResApp Expands into Management of Respiratory Disease-RAP.AX
18/08/16	PRICE SENSITIVE	83.81KB	Share
RAP Change of Auditor-RAP.AX
04/08/16		34.61KB	Share
RAP Appendix 4C - quarterly-RAP.AX
29/07/16	PRICE SENSITIVE	84.39KB	Share
RAP Bioshares Biotech Summit Presentation-RAP.AX
29/07/16		5.08MB	Share
RAP Section 708A Notice-RAP.AX
22/07/16		123.09KB	Share
RAP Appendix 3B-RAP.AX
22/07/16		561.27KB	Share
RAP ResApp Wins Category at the 2016 Talent Unleashed Awards-RAP.AX
22/07/16		69.15KB	Share
RAP Massachusetts General Hospital for US Clinical Study Site-RAP.AX
20/07/16	PRICE SENSITIVE	72.84KB	Share
RAP Becoming a substantial holder-RAP.AX
20/07/16		290.25KB	Share
RAP Appendix 3B-RAP.AX
15/07/16		149.05KB	Share
RAP Ceasing to be a substantial holder-RAP.AX
07/07/16		96.84KB	Share
RAP Ceasing to be a substantial holder-RAP.AX
07/07/16		94.81KB	Share
RAP Appendix 3B-RAP.AX
07/07/16		149.3KB	Share
RAP Response to ASX Price and Volume Query-RAP.AX
07/07/16	PRICE SENSITIVE	272.02KB	Share
RAP Update on US Clinical Study-RAP.AX
30/06/16	PRICE SENSITIVE	71.39KB	Share
RAP Appendix 3B-RAP.AX
28/06/16		149.11KB	Share
RAP Positive Preliminary Results from Adult Clinical Study-RAP.AX
21/06/16	PRICE SENSITIVE	112.38KB	Share
RAP Trading Halt-RAP.AX
20/06/16	PRICE SENSITIVE	365.45KB	Share
RAP Release of Restricted Securities-RAP.AX
10/06/16		86.94KB	Share
RAP Appendix 3B-RAP.AX
10/06/16		149.41KB	Share
RAP ResApp Provides Australian Adult Study Enrolment Update-RAP.AX
07/06/16	PRICE SENSITIVE	390.91KB	Share
RAP Appendix 3B - Exercise of Options-RAP.AX
02/06/16		149.46KB	Share
RAP Appendix 3B - Release of Restricted Securities-RAP.AX
02/06/16		148.8KB	Share
RAP Release of Restricted Securities-RAP.AX
18/05/16		88.55KB	Share
RAP Appendix 3B-RAP.AX
18/05/16		149.44KB	Share
RAP Ceasing to be a substantial holder-RAP.AX
16/05/16		49.29KB	Share
RAP Investor Presentation-RAP.AX
03/05/16		5.02MB	Share
RAP Appendix 4C - quarterly-RAP.AX
29/04/16	PRICE SENSITIVE	84.32KB	Share
RAP Appendix 3B and Issue of Cleansing Prospectus-RAP.AX
29/04/16		298.96KB	Share
RAP Cleansing Prospectus-RAP.AX
28/04/16	PRICE SENSITIVE	402.65KB	Share
RAP ResApp Completes Oversubscribed $12.5M Capital Raising-RAP.AX
20/04/16	PRICE SENSITIVE	80.21KB	Share
RAP TechKnow Invest Roadshow 2016 Presentation-RAP.AX
05/04/16		4.98MB	Share
RAP ResApp Provides Updated Paediatric Clinical Study Results
31/03/16	PRICE SENSITIVE	109.37KB	Share
RAP Director Resignation and Appendix 3Z
23/03/16		119.03KB	Share
RAP Change of Director's Interest Notice
18/03/16		77.54KB	Share
RAP Response to ASX Aware Query
17/03/16	PRICE SENSITIVE	751.45KB	Share
RAP ResApp Presentation at the ASX CEO Sessions
15/03/16		5.21MB	Share
RAP ResApp Completes Successful Pre-Submission Meeting with FDA
14/03/16	PRICE SENSITIVE	75.4KB	Share
RAP Terms of Executive Appointment
11/03/16		87.38KB	Share
RAP Response to ASX Price and Volume Query
11/03/16	PRICE SENSITIVE	238.77KB	Share
RAP ResApp Collaborates with Leading Humanitarian Organisation
07/03/16	PRICE SENSITIVE	70.88KB	Share
RAP Breakthrough Performance in Paediatric Clinical Study
02/03/16	PRICE SENSITIVE	95.7KB	Share
RAP Appendix 4D and Half Year Accounts
01/03/16	PRICE SENSITIVE	1.23MB	Share
RAP Second Site Added to Adult Clinical Study
26/02/16	PRICE SENSITIVE	69.69KB	Share
RAP Initial Director's Interest Notice
24/02/16		22.79KB	Share
RAP ResApp Appoints New Director
22/02/16		68.43KB	Share
RAP Investor Presentation
17/02/16		5.21MB	Share
RAP Appendix 3B
11/02/16		148.51KB	Share
RAP Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	84.13KB	Share
RAP Change in substantial holding
27/01/16		211.46KB	Share
RAP Appendix 3B
22/01/16		561.96KB	Share
RAP Conversion of Options and Issue of Cleansing Prospectus
22/01/16		67.09KB	Share
RAP Cleansing Prospectus
22/01/16	PRICE SENSITIVE	427.53KB	Share
RAP ResApp to Exhibit at Digital Healthcare Conference in Dubai
22/01/16		70.1KB	Share
RAP ResApp Files Pre-Submission Package with the US FDA
31/12/15		71.11KB	Share
RAP Appendix 3B
21/12/15		148.45KB	Share
RAP ResApp Receives Approval to Begin Adult Study
14/12/15	PRICE SENSITIVE	69.99KB	Share
RAP Release of Restricted Securities
04/12/15		87.89KB	Share
RAP Result of Annual General Meeting
30/11/15		134.33KB	Share
RAP CEO Presentation at Canary Networks Investor Roadshow
25/11/15		1.85MB	Share
RAP Becoming a substantial holder
16/11/15		71.43KB	Share
RAP US Roadshow - Investor Presentation
11/11/15		2.62MB	Share
RAP Further Positive Preliminary Results from Clinical Study
10/11/15	PRICE SENSITIVE	169.57KB	Share
RAP Trading Halt
06/11/15	PRICE SENSITIVE	201.42KB	Share
RAP Exhibitor at McKinsey Global Integrated Care Conference
04/11/15		103.38KB	Share
RAP Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	125.94KB	Share
RAP Notice of Annual General Meeting/Proxy Form
28/10/15		138.34KB	Share
RAP Dr Abeyratne to present at Pneumonia Innovations Summit
22/10/15		89.67KB	Share
RAP TechKnow Invest Roadshow Presentation
20/10/15		2.84MB	Share
RAP Change of Director's Interest Notice
12/10/15		36.05KB	Share
RAP Australia Biotech Invest Presentation
06/10/15		2.3MB	Share
RAP Appendix 4G
01/10/15		129.83KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

RAPTOR RESOURCES LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available